Methodologic pitfalls in assessing the efficacy of recombinant follicle-stimulating hormone versus human menopausal gonadotropin in assisted reproduction

By Daya S.  

Fertility and Sterility, Vol. 80, Iss. 5, 2003-11 ,pp. : 1100-1104

Elsevier

Access to resources Recommend Favorite

Use of recombinant human follicle-stimulating hormone in the treatment of male factor infertility

By Foresta C.   Bettella A.   Merico M.   Garolla A.   Ferlin A.   Rossato M.  

Fertility and Sterility, Vol. 77, Iss. 2, 2002-02 ,pp. : 238-244

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized, comparative trial

By The European and Israeli Study Group on Highly Purified Menotropin versus Recombinant Follicle-Stimulating Hormone  

Fertility and Sterility, Vol. 78, Iss. 3, 2002-09 ,pp. : 520-528

Elsevier

Access to resources Recommend Favorite

A prospective, randomized study to assess the tolerance and efficacy of intramuscular and subcutaneous administration of recombinant follicle-stimulating hormone (Puregon)

By Out H.J.   Reimitz P.E.   Coelingh Bennink H.J.T.  

Fertility and Sterility, Vol. 67, Iss. 2, 1997-02 ,pp. : 278-283

Elsevier

Access to resources Recommend Favorite

A prospective, randomized controlled trial comparing the efficacy of recombinant follicle-stimulating hormone in three different in vitro fertilization protocols

By Ravhon A.   Lawrie H.   Ellenbogen A.   Lavery S.   Trew G.   Winston R.  

Fertility and Sterility, Vol. 73, Iss. 5, 2000-05 ,pp. : 908-912

Elsevier

Access to resources Recommend Favorite